Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test a study drug called patritumab. Patritumab may work when
combined with other medications that are approved in the UK for treating Squamous Cell
Carcinoma of the Head and Neck (SCCHN), called cetuximab, cisplatin or carboplatin. It is
hoped that patritumab may have some benefit in treating patients with cancer. This study will
help identify how much patritumab can be given in combination with cetuximab, and cisplatin
or carboplatin. This study will show how safe and how well tolerated patritumab is when these
medications are given together.